621 Rose Street
44 articles with Celerion
Celerion , a leading clinical research organization (CRO) provider to the biopharmaceutical industry, will deliver a key address on the final day of the V
Celerion Recognized as 2020 CRO Leadership Champion for Reliability and Receives CRO Leadership Award for Capabilities, Compatibility, Expertise, and Quality
Celerion is proud to announce, for the fifth consecutive year, recognition of its early stage research development services across five categories in the 2020 CRO Leadership Awards sponsored by Life Science Leader and Industry Standard Research. Both small and large pharma respondents highlighted Celerion as a top performer in categories including Capabilities, Compatibility, Expertise, and Quality . Importantly,
Celerion announced today the expansion of specialized high-resolution mass spectrometry (HR-MS) profiling capabilities demonstrating their commitment to further assisting sponsors in meeting the regulatory requirements to characterize and quantify drug metabolites and their potential for impacting drug effect as part of the process to becoming an approved therapeutic product. Celerion has created a compelling bioanalytical
Celerion is proud to celebrate the 50th anniversary of the first clinical trial conducted at our facilities in Lincoln, Nebraska.
Celerion was recognized as a leader within the Small Pharmaceutical company group as well as a leader in the Overall group
Celerion, a leader in early clinical research, is pleased to announce the implementation of FibroScan® to complement a suite of soluble biomarkers Celerion has validated to support nonalcoholic steatohepatitis (NASH) clinical studies.
Celerion, the leader in early clinical development, is pleased to announce a new core capability for this growing market: the integration of ClinQuick, Celerion’s proprietary electronic data acquisition system, with TrialMaster, OmniComm’s electronic data capture solution, to provide a fully automated clinical trial data management platform.
Celerion Receives A 2017 CRO Leadership Award In Multiple Categories For Clinical Research Excellence
Celerion Implements Biometric Fingerprint Technology And Marks Five-Year Anniversary With Verified Clinical Trials
Celerion Recognized By Biopharmaceutical Clients As A Leader In Contract Research Quality Benchmarking Survey
Celerion Expands Ophthalmological Capabilities To Patient Populations In Collaboration With Queen’s University, Belfast.
Celerion Appoints Dr. Robert Lester As Chief Cardiologist, Global Medical Director Of Cardiac Safety Services
Celerion Selected By The Foundation For The National Institutes of Health (FNIH) Biomarkers Consortium For The Beta Cell Project
Celerion Establishes Business Presence In Singapore And Appoints Dr. Chew Lan Chong As Executive Director, Medical Research